Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GZPHF)
2.88
0.00 (0.00%)
USD |
OTCM |
Jun 17, 16:00
Guangzhou Baiyunshan Pharmaceutical Holdings Total Assets (Quarterly): 11.06B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.06B |
December 31, 2023 | 11.09B |
September 30, 2023 | 10.19B |
June 30, 2023 | 10.15B |
June 30, 2023 | 10.15B |
March 31, 2023 | 10.70B |
December 31, 2022 | 10.82B |
September 30, 2022 | 9.760B |
June 30, 2022 | 9.968B |
June 30, 2022 | 9.968B |
March 31, 2022 | 10.55B |
December 31, 2021 | 10.37B |
September 30, 2021 | 9.980B |
June 30, 2021 | 9.683B |
June 30, 2021 | 9.683B |
March 31, 2021 | 9.545B |
December 31, 2020 | 9.147B |
September 30, 2020 | 8.503B |
June 30, 2020 | 7.771B |
June 30, 2020 | 7.771B |
March 31, 2020 | 7.960B |
December 31, 2019 | 8.131B |
September 30, 2019 | 7.625B |
June 30, 2019 | 7.747B |
June 30, 2019 | 7.747B |
Date | Value |
---|---|
March 31, 2019 | 7.716B |
December 31, 2018 | 7.576B |
September 30, 2018 | 7.211B |
June 30, 2018 | 7.271B |
June 30, 2018 | 7.271B |
March 31, 2018 | 4.587B |
December 31, 2017 | 4.336B |
September 30, 2017 | 4.055B |
June 30, 2017 | 3.934B |
June 30, 2017 | 3.934B |
March 31, 2017 | 3.858B |
December 31, 2016 | 3.729B |
September 30, 2016 | 3.815B |
June 30, 2016 | 2.683B |
June 30, 2016 | 2.683B |
March 31, 2016 | 2.622B |
December 31, 2015 | 2.445B |
September 30, 2015 | 2.486B |
June 30, 2015 | 2.655B |
June 30, 2015 | 2.655B |
March 31, 2015 | 2.402B |
December 31, 2014 | 2.300B |
September 30, 2014 | 2.317B |
June 30, 2014 | 2.218B |
June 30, 2014 | 2.218B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.625B
Minimum
Sep 2019
11.09B
Maximum
Dec 2023
9.443B
Average
9.760B
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Sino Biopharmaceutical Ltd | 8.973B |
HUTCHMED (China) Ltd | 1.280B |
Pharmaron Beijing Co Ltd | 3.058B |
Regencell Bioscience Holdings Ltd | 12.62M |
Prenetics Global Ltd | 254.17M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.620B |
Shareholders Equity (Quarterly) | 5.182B |
Debt to Equity Ratio | 0.3591 |
Current Ratio | 1.640 |
Net Debt Paydown Yield | -1.21% |